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Prolactin and Prolactin Receptor Expression in Rat,
Small Intestine, Intraepithelial Lymphocytes During
Neonatal Developmen*
SANDRA L. URTISHAK, ELIZABETH A. McKENNA and ANDREA M. MASTRO
Department ofBiochemistry and Molecular Biology, The Pennsylvania State University, 431 S. Frear, University Park, PA 16802, USA
Intraepithelial lymphocytes (IEL) are specialized T cells found between the epithelial cells of
the small intestine. Because of their location, IEL are the first lymphocytes to contact intesti-
nal bacteria and food antigens. In the neonate, IEL may be the first cells of the immune sys-
tem to interact with milk-borne hormones including prolactin (PRL). PRL, an endocrine
hormone abundant in breast milk, interacts with cells through surface receptors. PRL has
been shown to function as an immunoregulator and may affect the development of the new-
born’s immune system. To determine if PRL plays a role in IEL development, small intestine
IEL from rats of various ages were examined for the presence of surface prolactin receptor
(PRL-R) and several lymphoid markers by flow cytometry. Between birth and 96 days of age
about 80% of IEL were found to express PRL-R. These same cells also expressed the mRNA
for PRL. Additionally, all of the IEL subpopulations examined were found to express PRL-R.
Analysis of the normal development of rat IEL revealed an age related increase in total IEL,
CD4 positive cells as well as a peak in interleukin-2 receptor (IL-2R) expression at weaning.
In summary, the results indicate that IEL express PRL and PRL-R. In addition, an activation
marker, IL-2R, changes in expression during neonatal development.
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INTRODUCTION
Evidence suggests that prolactin (PRL), a peptide hor-
mone secreted by the anterior pituitary, plays an
important role in immunoregulation as both hypoprol-
actinemia and hyperprolactinemia lead to a compro-
mised immune system (Reber, 1993). Additionally,
PRL induces the alpha chain of the interleukin-2
receptor (IL-2), a lymphocyte activation marker, on
splenocytes (Mukherjee et al., 1990); and activated
lymphocytes synthesize and secrete PRL (Pellegrini
et al., 1992). The PRL receptor (PRL-R) has been
found on circulating leukocytes (Russell et al., 1984)
as well as on splenocytes and thymocytes (Viselli and
Mastro, 1993; Koh and Phillips, 1993).
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PRL passes from the circulation of lactating rats to
the milk. The concentration and forms of PRL found
in milk suggest that it may be important for the
neonate as well as for the mammary gland. In fact,
maternal milk PRL has been found to pass into the
plasma of suckling rats (Whitworth and Grosvenor,
1978). Its role in the neonate is not clear but there is
evidence that PRL can regulate neonatal pituitary
development (Porter and Frawley, 1993), as well as
the development of the neonatal immune system
(Grove et al. 1991). In a previous study it was found
that milk ingestion during the first 7 hr. of life
decreased the percentage of splenocytes and thymo-
cytes expressing PRL-R (Gunes and Mastro, 1996).
Furthermore, splenocytes and thymocytes from neo-
natal rats ingesting PRL-poor milk showed an accel-
erated and increased response to mitogens when
tested ex vivo (Grove et al., 1991).
Because of their location, intraepithelial lym-
phocytes (IEL) present in the small intestine may rep-
resent the first interaction between milk-borne PRL
and the immune system. With the exception of one
study that identified mRNA for PRL and PRL-R in an
enriched mouse intestinal IEL preparation by PCR
(Nagano et al., 1995), the presence and role of PRL-R
on IEL has not been examined. In this study, our aim
was to determine if IEL expressed PRL and PRL-R, if
so what subpopulations were positive, and if this
expression changed during development or with milk
ingestion.
RESULTS
Isolation and Characterization of Rat IEL
The number of IEL recovered per intestine increased
with the age of the animal (Fig. 1). At birth < 1 x 106
IEL were recovered per intestine but later in the neo-
natal period the value increased to about 3 x 106. The
number continued to increase after weaning and
reached adult levels of about 13 x 106 per intestine
after about 50 days.
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FIGURE Total IEL recovered at various ages. IEL were isolated from the small intestines of Sprague Dawley rats following the procedure
of Kearsey and Studynk (1996) as described in the methods section. Shown are the average number of IEL S.E.M. per intestine. The num-
ber of intestines used per isolation varied with age (see Methods). There were 4 isolations for 0 days and 10 isolations for 3-7 days; 5 isola-
tions for 14-23 days, 6 isolations each for 25-50 days and 51-96 days and 10 isolations for > 100 daysPRL, PRL RECEPTORS ON IEL 321
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FIGURE 2 Flow cytometric characterization of IEL. IEL were isolated from the small intestine of Sprague Dawley rats and analyzed by flow
cytometry on a Coulter XL2 flow cytometer with Elite software. LCA expression was used to gate the lymphocyte population. Representa-
tive data from a 96 day male rat are shown. Dashed lines show the negative controls and solid lines show staining with the various lymphoid
markers and PRL-R. Values are the percentages of positively stained cells
In order to characterize the isolated cells and to
verify that they were indeed IEL, phenotyping was
carried out. Small intestine IEL from Sprague-Daw-
ley rats at ages between 0 and 270 days were exam-
ined by flow cytometry (Fig. 2). Depending on the
particular preparation, between 50% and 90% of the
isolated cells expressed leukocyte common antigen
(LCA). Since all lymphocytes express LCA and epi-
thelial cells do not, LCA expression was used as the
standard for flow cytometric gating. At all ages, an
average of 92.9% + 5.6% of the gated lymphocyte
population, expressed leukocyte common antigen
(LCA) (range 81.4 99.4%; n=29) (Table I, Fig. 2).
Of the LCA positive cells, 66.6% were also positive
for CD8. IEL expressed either the CD8cct
homodimer (43.9% + 8.7%) or the CD8oc[3 het-
erodimer (19.3%+ 9.9%). TCRoc[3 cells were 56.4% _+
7.7% of the total LCA positive cells while TCRT8322 SANDRA L. URTISHAK et al.
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FIGURE 3 Dual labeling of IEL for PRL-R and lymphoid markers. IEL were isolated from the small intestine of Sprague Dawley rats and
analyzed by flow cytometry on a Coulter XL2 flow cytometer with Elite software as described in the methods section. LCA expression was
used to gate the lymphocyte population. Data from a 96 day male rat are shown
(8.9% _+ 2.6%) expression was lower (Table I, Fig. 2).
CD4 expression was also detected in IEL but the per-
centage of IEL expressing CD4 varied with age (see
Fig. 4).PRL, PRL RECEPTORS ON IEL 323
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FIGURE 4 Change in CD4 expression with age. IEL were isolated
from Sprague-Dawley rats between 0 and 250 days old. After stain-
ing with a monoclonal antibody to CD4, IEL were analyzed by
flow cytometry. First degree polynomial regression was used to
generate the best fit line
TABLE Phenotype of rat small intestine IEL
Surface Marker Percentage of Cells
Total CD8 66.6 + 12.8
CD8otot 43.9 ___
8.7
CD8ot3 19.3 _
9.9
TCRcI3 56.4 _+ 7.7
TCR(6 8.9 _
2.6
PRL-R 82.3 6.4
Isolated IEL were phenotyped using antibodies and flow cyto-
metric analysis as described in the methods section.
a. The percentages of IEL expressing lymphoid markers were
normalized by setting LCA expression to 100% (range 81.4-
99.4%). For LCA the n value 29. For the other markers n=20
except PRL-R where n=12.
PRL-R Expression
The majority (82.3% _+ 6.4%) of LCA positive IEL
were found to express PRL-R (Table I, Fig. 2). In dual
labeling experiments, PRL-R expression was detected
on cells of each of the IEL sub-populations tested
(Fig. 3). Approximately 85% of TCRotl3 IEL (84.8% _
7.7%) and 84% of TCRT5 IEL (84.2% _+ 2.6%)
expressed PRL-R. PRL-R were also found in approxi-
mately 86% of the CD8 positive IEL (85.8% _
7.9%),
88% of the CD4 positive IEL (88.4% _+ 7.7%), and
89% of IEL expressing the CD8 chain (89.1% _
3.0%) (Fg. 3).
We also noted the presence of a subpopulation of
IEL cells that stained about 10 times more brightly for
PRL receptor and about 4 fold less brightly for LCA
than the bulk of the IEL (Fig. 3). These cells were
LCA/, CD4-, CDSot-, CD8-, TCRI3-, TCR75-. This
population made up about 15-20% of the total LCA
/
cells. Based on backgating and forward and side scat-
ter, these cells are not dead cells or epithelial cell con-
taminants. At this time these cells have not been
further characterized.
In order to determine if IEL expression of PRL-R
was affected by ingestion of milk PRL, we examined
IEL from a litter of newborn rats half of which were
permitted to suckle and half of which were kept warm
but not permitted to ingest milk. We found that
PRL-R expression was present on IEL at 10 hr. of age
regardless of whether milk had been ingested. We
also examined PRL-R throughout the neonatal period
and into adulthood. Although the percentage of IEL
expressing PRL-R did not change during develop-
ment, the relative intensity ofPRL-R did show a trend
to increase with age. The intensity of PRL-R expres-
sion was highly variable, but on average a minimal at
14 days of age and a maximal at 66 days of age.
Other Age Associated Changes in IEL
In the course of examining PRL-R expression, two
other age associated changes in IEL were identified.
First, the percentage of IEL expressing CD4 greatly
increased with age. CD4 expression averaged 4.6%
for rats 21 days and younger. However, by 250 days
of age 45-50% of IEL expressed CD4 (Fig. 4). Dual
labeling indicated that the increase in CD4 positive
cells was due to an increase in dual CD4 positive
CD8oot positive IEL. In two animals (141 days of
age) approximately 90% (89%, 92%) of the dual
labeled cells were of the CD8otc type.
Second, expression of the o chain of IL-2R was
found to vary with age (Fig. 5). An antibody to the ot
chain of the IL-2R labeled about 40% of IEL from 10
hr. old rats. IL-2R expression increased to 70% 75%
between 7 and 21 days of age and to approximately324 SANDRA L. URTISHAK et al.
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FIGURE 5 Change in IL-2R expression with age. IEL from Sprague Dawley rats were isolated and analyzed by flow cytometry after staining
with a monoclonal antibody to the chain of the IL-2 receptor. Values are shown as percentages one standard deviation, n=2 for all ages. One
way ANOVA indicated that IL-2R expression at times < 50 days varied significantly from that at > 50 days (p < 0.05)
85% at 25 days of age. However, by 96 and 154 days
of age, IL-2R expression had dropped to about 50%.
PRL Expression
Because other lymphocytes have been shown to
express PRL as well as PRL receptor, we asked if IEL
did the same. PRL mRNA was detected in all samples
of rat IEL tested from 0 to 150 days of age. The rela-
tive PRL mRNA levels for animals age 0, 1, 7, 14, 21,
28 and 150 days were 2.86, 2.34, 0.83, 22.34, 3.91,
1.00 and 2.23 respectively. This experiment was car-
fled out again with animals from 3, 14, 21, 28 to 52
days. The relative PRL mRNA levels were 2.52,
14.52, 2.60, 1.00 and 3.07. Day 28 values were set
equal to 1.00 in both series for comparison. With the
exception of a possible increase at day 14, the IEL
PRL mRNA levels remained relatively constant from
birth to 150 days of age.
DISCUSSION
As reported previously for PVG rats (Lyscom and
Brueton, 1983), IEL can be seen in the small intestine
at birth. However, they increased in numbers through-
out the neonatal period and reached adult levels
somewhere around 2 months of age. On average
about 10-15 x 106 IEL can be isolated per small
intestine of an adult rat following the procedure of
Kearsey and Stadnyk (1996).
IEL isolated from the small intestine of rats
between 0 and 270 days were found to be predomi-
nately (~70%) CD8 positive T cells. Approximately
56% of IEL expressed the cc TCR and 9% expressed
the 76 TCR. These values were very similar to those
of Kearsey and Stadnyk (1996), whose isolation pro-
cedure we followed. They found IEL of Lewis rats to
be approximately 70% CD8 positive, 75% TCRcc
positive, and 9% TCRT T cells. The data will also
agree with results of a recently published procedures
by Todd et al. (1999).
Ktihnlein et al. (1995) found a similar percentage
ofTCRT postitive T cells in Wistar rats. Human IEL
are approximately 10% TCR76 positive similar to the
rat. In contrast, mice IEL are 20-80% TCRT6 posi-
tive. Steege et al. (1997) reported 50% TCRT6 posi-
tive IEL by 20 days of age in mice. Since TCR76
positive and CD8cccc positive T cells are rare in other
lymphocyte populations, TCR76 and CD8cccc IELPRL, PRL RECEPTORS ON IEL 325
may develop in the intestine from T cell precursors
(Lefrancois, 1994). In Sprague Dawley rats about
70% of the CD8 positive IEL expressed the CD8oct
homodimer and the remaining 30% expressed the
CD8ct3 heterodimer. Like rat IEL, IEL from mice and
humans are predominately CD8 positive (90% in
mice, 80% in human) and the majority of CD8 posi-
tive IEL express the CD8aa homodimer in these spe-
cies (Lefrancois, 1994).
Based on our previous findings concerning PRL-R
expression by thymocytes and splenocytes, we were
interested in determining if IEL expressed PRL-R and
if this expression changed during development. More
than 80% of IEL expressed PRL-R, indicating that
IEL are capable of interacting with PRL. In contrast
to IEL only 17% of splenocytes (Viselli and Mastro,
1993) and 10% of thymocytes (Gunes and Mastro,
1996) express PRL-R in rats. The high percentage of
IEL expressing PRL-R indicate that PRL may be par-
ticularly important in the regulation of IEL. PRL-R
was identified on both TCRctl3 positive and TCRT
positive IEL as well as on CDSc positive, CD8tct
positive, and CD4 positive IEL. The presence of
PRL-R on all major IEL subpopulations suggests that
PRL plays a role in the regulation of both thymus
dependent and thymus independent IEL. Studies
underway in our laboratory indicate that both long
and short forms of PRL-R mRNA can be detected in
flow cytometrically sorted rat IEL.
Although the percentage of IEL expressing PRL-R
did not vary with age, the intensity of PRL-R did
increase with age. The intensity of PRL-R expression
is directly related to the number of PRL-R per cell.
However, there was a lot of variation and these exper-
iments will need to be verified.
We originally studied IEL from rats of different
ages to determine how PRL-R might change with
antigen exposure. While the percentages of cells
expressing PRL-R did not vary, the percentage of IEL
from Sprague Dawley rats expressing CD4 was found
to increase with age from about 5% for animals less
than 22 days to more than 45% at 250 days. By histo-
chemical methods Lyscom and Brueton (1983) were
not able to detect CD4+ rat IEL before 2 weeks of age.
However, by flow cytometry this small population at
birth was clearly seen. In a flow cytometric study with
mouse small intestinal IEL, Steege et al. (1997)
reported that the percentage of CD4+ cells increased
from 11% on day 20 to 30% on day 30.
In the present study, the increase in CD4 positive
IEL was not accompanied by a decrease in CD8 posi-
tive IEL. Therefore, the increase in CD4 positive IEL
is most likely due to an increase in CD4/CD8 dual
positive IEL. Takimoto et al. (1992) reported an
increase in CD4/CD8 dual positive IEL between 4
and 30 weeks in several other rat strains. In the
present study, dual labeling revealed that CD4 was
found primarily on CD8cc. Immature CD4/CD8 dou-
ble positive T cells are found in the thymus but are rare
in circulating lymphocyte populations and in most sec-
ondary lymphoid organs. Thus, the CD4/CD8ca dou-
ble positive IEL represent a population characteristic of
the intraepithelial immune system.
The t chain of IL-2R also showed an age associ-
ated change. As a marker of lymphocyte activation,
IL-2R is normally only present on activated lym-
phocytes. An increase in IL-2R expression by IEL
was seen between 0 and 25 days of age. The percent-
age of IEL expressing IL-2R peaked at 25 days and
then dropped to about 60% of the peak value by 96
days. The peak in percentage of activated IEL
occurred just after weaning. A peak in intestinal
immune system activity at weaning age has also been
reported in mesenteric lymph nodes and mast cells of
the intestine (Thompson et al., 1996). Steege et al.
(1997) reported similar peaks in IEL activity at about
the time of weaning. Since young rats begin eating
solid food before weaning, the increase in IEL activa-
tion is probably not caused solely by foreign antigens
in the solid food. However, it may reflect the removal
of exposure to hormone such as PRL and other factors
in milk. The greater percentage of IL-2R positive IEL
in milk-deprived rats supports the hypothesis that a
milk-borne factor suppresses IEL activation. Previous
studies have found that splenocytes and thymocytes
from neonatal rats fed PRL-poor milk showed an
increased response to mitogens (Grove et al., 1991).
Examination of IEL from neonates fed PRL-poor
milk could determine if IEL activation is specifically
related to PRL ingestion.326 SANDRA L. URTISHAK et al.
Rat somatotraphs do not produce PRL before day 5
(Hoeffler et al., 1985). Therefore the only source of
PRL in the newborn is milk (Kacsoh et al., 1993) or
locally produced PR1. While PRL is produced prima-
rily by the pituitary, several other cell types express it
as well, e.g. peripheral blood mononuclear cells (Sab-
harwal et al., 1992), splenocytes (Shah et al., 1991)
and thymocytes (Montogery et al., 1992). PRL’s func-
tion in these cells is not known, but it increases fol-
lowing cell activation (Montgomery et al., 1992). In
this study we found PRL mRNA to be expressed by
IEL from birth to relatively old age for the rat. We do
not have evidence that the protein is made and
secreted. However, Stevens and Show (1982) previ-
ously demonstrated the presence of immunoreactive
presence in the small intestine by immunohistochem-
istry. They did not determine which cells in the small
intestine were the source of the PRL. Our data sug-
gests that the IEL are a source of intestinal PRL.
The characteristic phenotype of IEL may make
these cells particularly well suited to immunological
defense in the intestine. However, there is still little
known about the development and in vivo function of
IEL. Our finding of both PRL and PRL-R expression
on the majority of IEL suggests that PRL plays some
role in the regulation of all IEL subpopulations. Addi-
tionally, early milk ingestion may help regulate the
activation of IEL.
Recent results from knockout mice lacking PRL-R
(Ormandy et al., 1997) or PRL (Horseman et al.,
1997) indicate that PRL is not necessary for life nor is
it apparently essential for the gross development of
the immune system. However, PRL like many
cytokines may act reduntantly, and its role as an
immunomodulator may be difficult to assess.
MATERIALS AND METHODS
Animals
Sprague-Dawley rats (Harlan Laboratories, Indianap-
olis, IN) were housed in a conventional animal facil-
ity at 20-22C on a 14 hr. light, 10 hr. dark cycle with
free access to food and water. Pups remained with
their mother until weaning at 21 days of age. All pro-
cedures were approved by the Animal Use and Care
Committee of the Pennsylvania State University.
Isolation of IEL
IEL were isolated from the small intestine of rats 14
days and older by a modified version of the procedure
of Kearsey and Stadnyk (1996). Briefly, the small
intestine from 1 cm below the stomach to 1 cm above
the large intestine was removed and divided in half.
Each half was flushed with PBS, everted, filled with
PBS and ligated at the ends with surgical thread. The
intestinal segments were placed in ice cold PBS con-
taining 2 mM dithiothreitol (DTT) and vortexed for
10 s. Intestine segments were then placed in complete
RPMI [5% v/v fetal bovine serum (FBS), 2 mM
L-glutamine, 10 mM HEPES buffer, 50 U/ml penicil-
lin, 50 gg/ml streptomycin] and vortexed for six
bursts of 15 s at the highest speed. Intestine segments
were discarded and the remaining cell suspension was
passed through two layers of cheesecloth. 1X Percoll
[10% (v/v), 10X PBS, 90% (v/v) Percoll (Sigma)]
was added to the cell suspensions to give 30% (v/v)
Percoll. Tubes were centrifuged at 500-550 x g for 15
min. at room temperature. Cells passing through the
30% Percoll were resuspended in 45 % (v/v) 1X Per-
coll in complete RPMI-1640 medium and layered
above an equal volume of 75% (v/v) 1X Percoll in
complete RPMI-1640 medium. The gradients were
centrifuged at 500-550 x g for 30 min. at room tem-
perature. Cells were recovered from the 45-75%
interface and washed three times in complete
RPMI-medium. Cell viability was consistently deter-
mined to be greater than 95% by trypan blue exclu-
sion. For animals 50 days and older, recovery of IEL
averaged 13 x 106 cells per intestine. IEL recovery
averaged 5.7 x 106 cells per intestine for rats between
25 and 50 days of age.
For animals younger than 14 days of age where
intestines were too small to be inverted, the intestine
was removed, flushed with PBS, opened longitudi-
nally, and cut into 1 cm sections. The sections were
placed in PBS with 2mM DTT and the cells were iso-PRL, PRL RECEPTORS ON IEL 327
lated as described for the larger segments. For rats
between 11 and 23 days average recovery of IEL was
3.7 x 106 per intestine. An average recovery of 0.8 x
106 cells per intestine was obtained for animals
between 0 and 7 days of age.
Antibodies
The following antibodies were used for flow cytomet-
ric analysis: MRC OX-1 (anti-leukocyte common
antigen LCA), MRC OX-8 (anti-CD8 c-chain),
W3/25 (anti-CD4), OX-39 (anti-IL-2 receptor), [pur-
chased from Serotec Inc., Raleigh, NC]; R73 and
Rphycoerythrin (PE) conjugated R73 (anti-al3 T cell
receptor), V65 and R-PE conjugated V65 (anti-76 T
cell receptor), R-PE conjugated OX-8 (anti-CD8
c-chain), fluorescein isothiocyanate (FITC) conju-
gated 341 (anti-CD8 3-chain), MRC OX-33
(anti-CD45, B cell form), PE and FITC conjugated
107.3 (Mouse IgG 1, c isotype control) [purchased
from Pharmingen, San Diego, CA]. FITC conjugated
rabbit anti-mouse IgG HpositiveL and biotin conju-
gated donkey anti-rabbit IgG HpositiveL were pur-
chased from Jackson Laboratories (West Grove, PA).
R-PE Cy5 conjugated Streptavidin was purchased
from DAKO (Carpinteria, CA).
A polyclonal antibody to PRL-R was a generous
gift from Dr. Kurt Ebner, University of Kansas. This
antiserum has been characterized in our laboratory
(Viselli and Mastro, 1993) and in that of Kurt Ebner
(Ebner et al., 1989, Bajpai et al., 1991). Ebner et al.
(1989) showed that the anti-PRL receptor serum stim-
ulated proliferation of Nb2 cells, a PRL dependent,
PRL receptor positive cell line, presumably because
binding of the antibody to the receptor mimics bind-
ing of PRL. In addition, binding of the anti-PRL
receptor antibody to Nb2 cells, detected by use of a
fluorescently labeled secondary antibody and fluores-
cence microscopy, decreased when the cell PRL
receptors were first downregulated in the presence of
PRL (Ebner et al., 1989). The antibody also inhibits
PRL induced DNA synthesis in a normal splenocyte
assay for PRL (Viselli and Mastro, 1993). This inhibi-
tory activity was removed by pre-incubation with
PRL receptor positive Nb2 cells; while antiserum
adsorbed with rat red blood cells retained its ability to
inhibit proliferation. Normal rabbit serum had no
affect on DNA synthesis.
For flow cytometric analysis, the antiserum to PRL
receptor was compared with normal rabbit serum and
with irrelevant polyclonal rabbit serum to myosin
light chain. Only between 1 and 2% of the cells were
positive with either control. In addition, dilution of
the anti-PRL serum with irrelevant rabbit serum (anti
myosin light chain) did not change the percentage of
positive lymphocytes. Pre-adsorption of the antiserum
with PRL receptor positive Nb2 cells decreased stain-
ing to lymphocytes to near background levels (Viselli
and Mastro, 1993).
Immunofluorescent Staining and Analysis
All antibodies were diluted in PBS with 5% calf
serum, 2% goat serum and 0.1% NaN3 and used at
saturating concentrations of 1 tg/1 xl06 cells. For
single color immunofluorescence, cells were incu-
bated with diluted primary antibodies for 25 min at
4C. Cells were washed twice in PBS with 5% calf
serum, 2% goat serum and 0.1% NaN3 and incubated
with the secondary, FITC conjugated antibody. The
cells were washed twice as described and stored in
1% formaldehyde in PBS in the dark at 4C until
analysis, usually within 2 days.
For two color immunofluorescent analysis, cells
were incubated with saturating concentrations of
anti-PRL-R serum and monoclonal antibodies for 25
min. at 4C. After two washes in PBS with 5% calf
serum, 2 % goat serum and 0.1% NaN3, cells were
incubated with FITC rabbit conjugated anti-mouse
IgG HpositiveL and biotin conjugated donkey
anti-rabbit IgG HpositiveL for 25 min. at 4C. Cells
were washed twice as above and incubated with Cy5
conjugated streptavidin diluted 1/10 (50 tl / 0.25 x
106 cells). After two washes, cells were stored in 1%
formaldehyde in PBS in the dark at4C until analysis.
Samples were analyzed with a Coulter XL2 flow
cytometer. Tight forward and side scatter gates were
set using LCA expression to eliminate contaminating
epithelial and presumed dead cells. Backgating was
used to verify that the various populations were con-328 SANDRA L. URTISHAK et al.
tained within that gate. In double labeling experi-
ments, compensation was set using the individually
labeled antibodies with each fluorochrome.
When primary control antibodies of the same iso-
type as the mouse monoclonal antibodies were used,
less that 3% of the gated cells were positive. The
same low background labeling was seen when the
secondary antibodies, FITC conjugated rabbit
anti-mouse IgG and biotin conjugated anti-Rabbit
IgG with R-PEcy5 conjugated streptavidin, were used
in the absence of the primary antibody. These back-
ground values were subtracted from the experimental
values. The percentage of cells expressing the
CD8cc homodimer was determined by subtracting
the percentage of cells that were labeled with the anti-
body to CD8a[3.
Isolation ofRNA and quantitative PCR
Isolated IEL were incubated with antibodies to CD8c
and to LCA and FITC conjugated rabbit anti-mouse
antibodies and sorted based on FITC fluorescence and
lymphocyte-indicative forward angle and side angle
light scatter using either a Coulter EPICS 753 (exper-
iment 1) or a Coulter EPIC ELITE (experiment 2)
(Coulter, Fullerton, CA) flow cytometer. A sample of
the sorted cells was re-run through the flow cytometer
to confirm purity. Post-sort IEL were 99.6 and 99.7%
pure.
Up to 1.5 x 106 of the sorted IEL were lysed by
vortexing in 400 gf of guanidinium isothiocyanate
(Gibco BRL, Grand Island, NY), 10% -mercaptoeth-
anol (Sigma Molecular Biology Grade, St. Louis) and
stored at- 80 C.
Frozen cell lysates were thawed at RT, incubated in
a 37C water bath for 10 minutes, and total RNA
recovered using the Gibco BRL GlassMAX Total
RNA Isolation Spin Cartridge System (Gibco BRL,
Grand Island, NY) (experiment 1) or the QIAGEN
RNeasy system and QIAshredder (QIAGEN Inc.,
Chatsworth, CA) (experiment 2) and stored at- 80C
in DEPC-treated H20. Total RNA was quantified via
UV absorbance readings at 260 nm derived from a
scan of absorbances ranging from 310 to 210 nm in a
UV/Vis spectrophotometer (DU-40, Beckman Instru-
ments Inc., Fullerton, CA).
Contaminating genomic DNA contained in some
samples was removed by treatment with Dnase I
(Gibco BRL, Grand Island, NY) under conditions
described in the GlassMAX Total RNA Isolation Spin
Cartridge System manual (Gibco BRL, Grand Island,
NY).
DNA primers for PCR were Synthesized by the
Penn State Nucleic Acid Facility (University Park,
PA) on an Oligo 1000M DNA Synthesizer (Beckman
Instruments Inc, Fullerton, CA). PRL forward primer,
5’ GGA AGT GTG GTC CCA GTG GT 3’, anneals to
nucleotides 25-44. PRL reverse primer, 5’ TGG CAG
GGT CTG CAC ATT T3’, anneals to nucleotides
11-123. PRL fluorogenic probe, 5’ FAM-AAC AGC
CAG GTG TCA GCC CGG AAA G-TAM 3’(synthe-
sized by Synthetic Genetics, San Diego), anneals to
PRL eDNA nucleotides 55-79. (PRL eDNA sequence
as numbered in Cooke et al., 1980).
All quantitative RT-PCR reactions were run by the
Penn State Nucleic Acid Facility on an ABI PRISM
7700 Sequence Detector (Perldn-Elmer, Foster City,
CA). For each reverse transcription reaction, total
RNA samples were incubated 5 minutes at 65C, then
placed on ice. 2.5 ul (experiment 1:1 to 2 ng; experi-
ment 2:25 to 80 ng) of total RNA were added to 17 ul
of reaction mixture containing the following: 1 U
RNase Inhibitor; 1X Buffer; 5 mM MgC12; 500 uM of
each dNTP, A, C, G, T; 750 nM reverse primer; 22 U
Reverse Transcriptase. Each complete reaction mix-
ture was incubated 1 hour at 42C, 5 minutes at 72C,
2 minutes at 25C.
Standard controls used by the Penn State Nucleic
Acid Facility (University Park, PA) for RT-PCR of rat
target mRNA were run for each sample of silEL total
RNA. The control reactions measured RNA encoding
rat ribsomal phosphoprotein PO (RPPO) which is
constitutively expressed in all rat cells. The primers
and probe sequences for RPPO are in file with the
Nucleic Acid Facility.
Quantitative RT-PCR data analysis was performed
using the Comparative C Method described in the
ABI PRISM 7700 Sequence Detection User Bulletin
#2, PE Applied Biosystems, 11 December 1997.PRL, PRL RECEPTORS ON IEL 329
For each PCR reaction, 8 gl (40%) of the RT reac-
tion products (cDNA) were added to 42 gl of PCR
reaction mixture containing the following: 1U Ampli-
Taq Gold (PE Applied Biosystems); 4 mM MgC12;
600 nM forward primer; 400 nM reverse primer; 200
uM of each dNTP, A, C, G, T; 100 nM fluorogenic
probe. Reactions were hot started by incubation for 10
minutes at 95C. Reactions were then cycled 40 times
as follows: 15 seconds at 95, and 1 minute at 60C.
The AW#42 plasmid (provided by Ameae M.
Walker, University of California, Riverside) consists
of the 823 bp pre-PRL cDNA inserted into pBR322.
Ten-fold serial dilutions (range: 2.3 x 102 to 2.3 x 106
copies) of AW#42 plasmid were used in reactions to
generate a standard curve of threshold cycle versus
starting copy number of plasmids. Data were plotted
and the equation of the line was generated using
Microsoft Excel.
The relative intensity of fluorescence was taken
directly from the mean channel fluorescence intensity
as calculated by the Coulter XL2 software statistics.
Coulter defines the mean intensity as Z log to lin
(channel number) x (counts in that channel)/area.
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